MELISSA LEUENBERGER: Open Payments
NPI 1861433187 · OLIVE HILL, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$438 in 24 payments from 10 companies in 2025. Trend: 2023 $275 · 2024 $405 · 2025 $438
Food & beverage: $438
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $87 |
| AstraZeneca Pharmaceuticals LP | 4 | $77 |
| Lilly USA, LLC | 4 | $66 |
| PFIZER INC. | 4 | $63 |
| Vanda Pharmaceuticals Inc. | 2 | $52 |
| Amgen Inc. | 1 | $23 |
| Exact Sciences Corporation | 1 | $20 |
| Corcept Therapeutics | 1 | $19 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $17 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
Products named: NURTEC ODT, Rybelsus, MOUNJARO, BREZTRI, Ozempic, FANAPT, JARDIANCE, OTEZLA.
Industry payments across KY — which companies pay providers there.
